1. Home
  2. NRDY vs ANVS Comparison

NRDY vs ANVS Comparison

Compare NRDY & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nerdy Inc.

NRDY

Nerdy Inc.

N/A

Current Price

$5.65

Market Cap

52.2M

Sector

Technology

ML Signal

N/A

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

N/A

Current Price

$0.92

Market Cap

48.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NRDY
ANVS
Founded
2007
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.2M
48.2M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
NRDY
ANVS
Price
$5.65
$0.92
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
★ $24.38
$10.50
AVG Volume (30 Days)
22.1K
★ 3.0M
Earning Date
11-09-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
13.16
★ 39.39
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.57
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.62
52 Week High
$11.03
$5.50

Technical Indicators

Market Signals
Indicator
NRDY
ANVS
Relative Strength Index (RSI) 41.32 43.86
Support Level $5.37 $0.62
Resistance Level $11.03 $1.41
Average True Range (ATR) 0.46 0.14
MACD 0.02 -0.00
Stochastic Oscillator 13.66 35.61

Price Performance

Historical Comparison
NRDY
ANVS

About NRDY Nerdy Inc.

Nerdy Inc operate a next-generation live tutoring and intervention platform that leverages the power of human expertise with Developed artificial intelligence (AI) to personalize learning, accelerate student achievement, and empower educators. The company's proprietary platform leverages technology, including AI, to connect learners with instructors across a wide range of subjects and formats, including subscription-based learning, one-on-one instruction, small group tutoring, large-format classes, and assessments. Its flagship business operates under the Varsity Tutors brand. The company's offerings are available directly to students and consumers, as well as through schools and other institutions.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: